AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Impact of MRD Negativity on Treatment Discontinuation in Multiple Myeloma Patients
This chapter explores the significance of MRD negativity in guiding treatment discontinuation for multiple myeloma patients, focusing on a study assessing the effects of stopping maintenance therapy for MRD negative patients. The discussion includes insights on cost savings, effectiveness of stopping lenalidomide, comparisons of assay standards, and considerations for halting maintenance therapy based on MRD negativity. The chapter also touches on the benefits of treatment breaks for patient quality of life and highlights ongoing MRD-guided trials in the field.